Sovremennaya kontseptsiya lecheniya ozhireniya
https://doi.org/10.14341/2071-8713-5191
Abstract
Obesity is an unsolved problem of modern society, furthermore it is one of the main risk factors for type 2 diabetes mellitus, cardiovascular
diseases and cancer, pathology of musculoskeletal and digestive systems, reproductive disfunction both for women and for men.
It is known that treatment any chronic disease is rather complicated, not only for doctors but also for the patient, because it requires from
the patient a careful self-control and substantial changes in lifestyle. In modern clinical practice, various methods of treatment of obesity are
used: diet therapy, exercise therapy, physiotherapy, pharmacotherapy, psychotherapy and surgery. Modern methods of treatments of obesity
are reviewed in this article
diseases and cancer, pathology of musculoskeletal and digestive systems, reproductive disfunction both for women and for men.
It is known that treatment any chronic disease is rather complicated, not only for doctors but also for the patient, because it requires from
the patient a careful self-control and substantial changes in lifestyle. In modern clinical practice, various methods of treatment of obesity are
used: diet therapy, exercise therapy, physiotherapy, pharmacotherapy, psychotherapy and surgery. Modern methods of treatments of obesity
are reviewed in this article
References
1. Адрес в сети интернет: http://www.who.int/en/
2. Бутрова С.А. Терапия ожирения. Ожирение: этология, патогенез, клинические аспекты / Под редакцией И.И. Дедова, Г.А. Мельниченко. - М.: Медицинское информационное агентство, 2004. - С. 378-405.
3. Бутрова С.А. Лечение ожирения (Рекомендации для врачей). М., 2000. -21 с.
4. Дедов И.И., Бутрова С.А. Савельева Л.В. Обучение больных ожирением (Программа). М., 2001. - 52 с.
5. Диагностика и лечение ожирения у взрослых. Рекомендации Российской ассоциации эндокринологов. М., 2010. - № 12.
6. Дзгоева Ф.Х. Диетотерапия ожирения: от снижения массы тела до коррекции факторов риска сердечно-сосудистых заболеваний // Ожирение и метаболизм. - 2008. - № 4. - С. 25-29.
7. Мельниченко Г.А., Романцова Т.И. Ожирение: эпидемиология, классификация, патогенез, клиническая симптоматика и диагностика. Ожирение: этология, патогенез, клинические аспекты / под редакцией И.И. Дедова, Г.А. Мельниченко. - М.: Медицинское информационное агентство, 2004. - С. 16-42.
8. Национальные рекомендации по диагностике и лечению метаболического синдрома // Кардиоваскулярная терапия и профилактика. - 2007. - № 6(6). Приложение 2.
9. Савельева Л.В. Эффективность терапевтического обучения больных в комплексном лечении ожирения. Диссертация на соискание ученой степени к.м.н. Москва, 2004.
10. Яшков Ю.И. Стандарты в бариатрической и метаболической хирургии (по материалам международных согласительных конференций) // Ожирение и мета- болизм. - 2008. - № 3(16). - С. 17-21.
11. Яшков Ю.И. Хирургические методы лечения ожирения Ожирение: этология, патогенез, клинические аспекты / под редакцией И.И. Дедова, Г.А. Мельниченко. - М.: Медицинское информационное агентство, 2004. - С. 407-428.
12. Astrup A., Grunwald G. The role of low-fat diets in body weight control: a metaanalysis of ad libitum dietary intervention studies // Int J Obes. - 2000. - № 24. - Р. 1545-1552.
13. Barte J.C.M., Ter Bogt N.C.W., Bogers R.P. Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review // Obesity Reviews. - 2010. - № 11(12). - Р. 899-906.
14. Bray G.A. Contemporary diagnosis and management of obesity. Newtown, Pennsylvania. - 1998. - P. 289.
15. Bray G.A. Evaluation of drugs for treating obesity // Obes Res. -1995. - № 3(4). - 425S-434S.
16. Caballero B. The global epidemic of obesity: an overview // Epidemiol Rev 2007. - № 29. - Р. 1-5.
17. Finer N., James W.P.T, Kopelman P.G. et al. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor // Int J Obes. - 2000. - № 24. - Р. 306-313.
18. Florentin M., Liberopoulos E.N., Elisaf M.S. Sibutramine-associated adverse effects: a practical guide for its safe use. // Obesity Reviews. - 2008. - № 9. - Р. 378-387.
19. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic and surgical options // Obes Res. - 2002. - № 10. - 116S-123S
20. Halford J.C.G., Boyland E.J., Cooper S.J. et al. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women // J Psychopharmacol. - 2010. - № 24. - Р. 99-109.
21. Heymsfield S.B, Segal K.R, Haupman J. et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults // Arch Intern Med. - 2000. - № 5(8). - Р. 1321-1326.
22. International Obesity Taskforce prevalence data: global obesity prevalence in adults. London: The International Association for the Study of Obesity. (http://www. iotf.org/database/index.asp.)
23. Lichtenstein A., Appel L., Brands M., Carnethon M. and al. Diet and Lifestyle Recommendations Revision 2006. A Scientific Statement from the American Heart Association Nutrition Committee // Circulation. - 2006. - № 114. - Р. 82-96.
24. Meara S.O., Riemsma R., Shirran L. A systematic review of the clinical effectiveness of orlistat used for the management of obesity // Obesity Reviews. - 2004. - № 35(1). - Р. 51-68.
25. Miller W., Koceja D., Hamilton E. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention // Int J Obes. - 1997. - № 21. - Р. 941-947.
26. Ryttig K., Flaten H., Rossner S. Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet + behavior modification and their combination // Int J Obes. - 1997. - № 21. - Р. 574-579.
27. Ryttig K., Rossner S. Weight meitenance after a very low calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A prospective, randomized, comparative, controlled long term trial // J Intern Med. - 1995. - № 238 (4). - Р. 299-306.
28. The practical guide; identification, evaluation and treatment of overweight and obesity in adults. Update. www.nhlbi.nih.gov/guidelines/obesity/obesity2/index.htm.
29. WHO. Obesity: Preventing and Managing the Global Epidemic. World Health Organization: 2000.
30. Wilding J.P.H. Treatment strategies for obesity // Obesity Reviews. - 2007. - № 8 (s1). - Р. 137-144.
31. W. Philip T. James, M.D. and al. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects // N Engl J Med. - 2010. - № 2. - Р. 905-917.
32. Zavoral J.H. Treatment with orlistat reduces cardiovascular risk in obese patients // J. of Hypertension. - 1998. - № 16. - Р. 2013-2017.
Review
For citations:
Sovremennaya kontseptsiya lecheniya ozhireniya. Obesity and metabolism. 2011;8(1):51-56. (In Russ.) https://doi.org/10.14341/2071-8713-5191
Views:
816
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
